* If you want to update the article please login/register
Since the expression of β-adrenoceptors in the A431 squamous cell carcinoma human cells was explained, we had suggested that cSCC expansion may be managed by using β-AR-blockers. Our results have shown that the addition of 2DG to -Propranolol Hydrochloride therapy can improve its result on A431 cells metabolic process and spreading, suggesting that the combination of -Propranolol Hydrochloride with reduced dose of 2DG might be an encouraging treatment to be topically used as an adjuvant pre-surgical therapy against cSCC, aiming to lower the dimension of the injury prior to the operation, avoiding systemic adverse impacts to the individual.
Source link: https://europepmc.org/article/PPR/PPR401863
* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions